132 related articles for article (PubMed ID: 21821978)
1. [All-trans retinoic acid and arsenic trioxide: their molecular mechanisms of action and updated clinical progress in APL therapy].
Shinagawa K
Rinsho Ketsueki; 2011 Jul; 52(7):469-83. PubMed ID: 21821978
[No Abstract] [Full Text] [Related]
2. The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies.
Rice KL; de Thé H
J Intern Med; 2014 Jul; 276(1):61-70. PubMed ID: 24635409
[TBL] [Abstract][Full Text] [Related]
3. [Treatment for acute promyelocytic leukemia].
Fujita H
Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
[No Abstract] [Full Text] [Related]
4. Successful post-remission therapy with a combination of all-trans retinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia.
Kobayashi Y; Hatta Y; Ishizuka H; Hirabayashi Y; Tanaka T; Takei K; Takeuchi J
Int J Hematol; 2010 Jan; 91(1):152-3. PubMed ID: 20033799
[No Abstract] [Full Text] [Related]
5. Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapies.
Arteaga MF; Mikesch JH; Fung TK; So CW
Br J Cancer; 2015 Feb; 112(3):413-8. PubMed ID: 25247321
[TBL] [Abstract][Full Text] [Related]
6. Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia.
Zhang X; Pan J
Ann Hematol; 2017 Apr; 96(4):707-708. PubMed ID: 28154895
[No Abstract] [Full Text] [Related]
7. Contemporary treatment of APL.
Cull EH; Altman JK
Curr Hematol Malig Rep; 2014 Jun; 9(2):193-201. PubMed ID: 24643310
[TBL] [Abstract][Full Text] [Related]
8. Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.
Westervelt P; Pollock JL; Oldfather KM; Walter MJ; Ma MK; Williams A; DiPersio JF; Ley TJ
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9468-73. PubMed ID: 12077315
[TBL] [Abstract][Full Text] [Related]
9. Differentiating agents in pediatric malignancies: all-trans-retinoic acid and arsenic in acute promyelocytic leukemia.
Calleja EM; Warrell RP
Curr Oncol Rep; 2000 Nov; 2(6):519-23. PubMed ID: 11122887
[TBL] [Abstract][Full Text] [Related]
10. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
Iland HJ; Wei A; Seymour JF
Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
12. [Pathogenesis of Acute Promyelocytic Leukemia].
Matsushita H
Rinsho Byori; 2015 May; 63(5):631-42. PubMed ID: 26524903
[TBL] [Abstract][Full Text] [Related]
13. [Effects of combination therapy with all-trans retinoic acid and arsenic trioxide on acute promyelocytic leukemia].
Zhang GC; Zheng D; Li QH; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Apr; 23(4):430-4. PubMed ID: 15087033
[TBL] [Abstract][Full Text] [Related]
14. Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old child.
Rock N; Mattiello V; Judas C; Huezo-Diaz P; Bourquin JP; Gumy-Pause F; Ansari M
Pediatr Hematol Oncol; 2014 Mar; 31(2):143-8. PubMed ID: 24498972
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient.
Peterlin P; Garnier A; Tissot A; Garandeau C; Houreau-Langlard D; Hourmant M; Vantyghem S; Bonnet A; Guillaume T; Béné MC; Le Gouill S; Moreau P; Chevallier P
Ann Hematol; 2016 Oct; 95(10):1737-8. PubMed ID: 27465153
[No Abstract] [Full Text] [Related]
16. Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease.
Visani G; Piccaluga PP; Martinelli G; Rossi M; Malagola M; Baccarani M
Haematologica; 2003 Apr; 88(4):ELT15. PubMed ID: 12681992
[No Abstract] [Full Text] [Related]
17. Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.
Huang H; Qin Y; Xu R; You X; Teng R; Yang L; Xu M; Liu H
Leuk Res; 2012 Jul; 36(7):841-5. PubMed ID: 22534100
[TBL] [Abstract][Full Text] [Related]
18. How to manage acute promyelocytic leukemia.
Mi JQ; Li JM; Shen ZX; Chen SJ; Chen Z
Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid.
Breccia M; Molica M; Efficace F; Minotti C; Latagliata R; Foà R; Lo Coco F
Br J Haematol; 2014 Nov; 167(3):428-30. PubMed ID: 24957334
[No Abstract] [Full Text] [Related]
20. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
Ma J
Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
[No Abstract] [Full Text] [Related]
[Next] [New Search]